R&D is the lifeblood of J. B. Chemicals & Pharmaceuticals Ltd.. Our R&D efforts have so far yielded 18 International Patents and our scientists have discovered 20 New Molecules in NSAID therapeutic segments.
Four state-of-the-art R&D laboratories at thane, Panoli & Ankleshwar match superior standards. |
| |
| Focus:, Our current and future R&D activities will focus on development of Generic Products for Regulated as well as semi regulated Markets. |
| |
J. B. Chemicals & Pharmaceuticals Ltd. can deliver following package as a total Drug Product development:
| |
• |
Formulation Development |
| |
• |
Analytical Development |
| |
• |
Scale up batches |
| |
• |
Pilot / ANDA /ANDS / Submission batches |
| |
• |
Bio-study |
| |
• |
Dossier Compilation |
| |
• |
Validation batches |
| |
• |
Commercial Production |
|
| |
Technical Capabilities of R&D
| |
• |
Solid dosage formulations such as Tablets, Capsules, pellets. |
| |
• |
Injectables |
| |
• |
Dental preparations |
| |
• |
Ophthalmic preparation-solutions, Suspensions, Gels, Ointments |
| |
• |
Dermatologicals – Gels, Creams, Ointments. |
|
| |
GMP facilities for solid dosage forms & Parenterals.
| |
• |
Labscale (R&D) |
| |
• |
Pilot Facility |
| |
• |
Commercial Production |
All equipment for above mentioned facilities are from the same SUPAC category to facilitate the Scale up exercise & commercial production at Panoli Site, Gujrat. |
| |
Novel Drug Delivery Systems (NDDS) efforts concentrate on:
Controlled Release: Our research concentrates on sustained, delayed and Osmotic release. The company introduced a Novel Insoluble Drug Absorption Technology (NIDAT) for Nicardia CD and has also received a patent for Ranitidine controlled release tablets in U.S.A. and Nifedipine sustained release tablets in South Africa and Kazakhstan.
Novel Dosage Formulations: In the novel dosage form, the company concentrates on following therapeutic segments covered by NDDS
| |
• |
Cardiac Care |
| |
• |
Anti-infectives |
| |
• |
Anti-diabetics |
|
| |
Abbreviated New Drug Application (ANDA)
The company markets its approved ANDA products in USA thru its distributor. The company will be filing three to four ANDAs every year to address the growing opportunity in the U.S.A.
| |
• |
The Commercial Production site has been approved by USFDA. |
|
| |
Herbal Products
The company focuses on specialty natural herbal formulation the following products: Fitovit - Herbal Fitness Capsules, Zecuf- similar to Doktor Mom, launched in India, and Doktor Mom Lozenges - in Seven New Flavours (pineapple, strawberry, raspberry, lemon and orange) launched in Russia.
R&D plays a vital supportive role for other corporate functions as well such as quality assurance, regulatory affairs and intellectual property rights .
A team of dedicated doctors and research scientists are continuously working towards breakthrough and development of new products and processes. Validation team from all concerned departments successfully transfers the drug product from R&D to Commercial Production. |
| |
New Chemical Entities (NCE)
The company's initiative in the NCE segment bore fruit following the discovery of the possible COX 2 inhibitor in the anti-inflammatory segment. The company has invented 20 new molecules for patents and has been granted the patent. |
| |
 Top |
| |
| R & D Milestones | Quality | Technology | Patents |
